IGA NEPHROPATHY AND RISKS OF KIDNEY AND CARDIOVASCULAR EVENTS AND DEATH: THE KNIGHT STUDY

WCN23-0469
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
 
 
 
 
IGA NEPHROPATHY AND RISKS OF KIDNEY AND CARDIOVASCULAR EVENTS AND DEATH: THE KNIGHT STUDY
Tan, T.(1)*;Parikh, R.(1);Mahapatra, A.(2);Perkins, R.(3);Go, A.(1,4,5,6);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Kaiser Permanente Northern California, Division Of Research, Oakland, United States;(2)Kaiser Permanente Santa Clara Medical Center, Department Of Nephrology, Santa Clara, United States;(3)Novartis Pharmaceuticals Corporation, Nephrology, East Hanover, United States;(4)Kaiser Permanente Bernard J. Tyson School Of Medicine, Department Of Health Systems Science, Pasadena, United States;(5)University Of California- San Francisco, Departments Of Epidemiology- Biostatistics And Medicine, San Francisco, United States;(6)Stanford University School Of Medicine, Department Of Medicine Nephrology, Palo Alto, United States;
https://storage.unitedwebnetwork.com/files/1041/fc5a0c9b38ef64a28b2aa1fe44793084.pdf
 
if any